Abstract
Infection with Chlamydia trachomatis accounts for the most common bacterial sexually transmitted infection in the UK. Men between 20 and 24 years and women between 16 and 19 years have the highest prevalence of chlamydial infection. Because the majority of women with chlamydial infection are asymptomatic, a proportion remains untreated and eventually develops pelvic inflammatory disease (PID). PID can result in ectopic pregnancy, infertility and chronic pelvic pain. Screening for chlamydial infection might reduce the incidence of complications of PID. The advent of nucleic acid amplification tests and single-dose therapy for chlamydial infection has made home testing and easy treatment possible.
MeSH terms
-
Adolescent
-
Adult
-
Anti-Bacterial Agents / therapeutic use
-
Anti-Infective Agents / therapeutic use
-
Chlamydia Infections* / complications
-
Chlamydia Infections* / diagnosis
-
Chlamydia Infections* / drug therapy
-
Chlamydia Infections* / epidemiology
-
Chlamydia trachomatis / isolation & purification*
-
Conjunctival Diseases / etiology
-
Contact Tracing
-
Female
-
Genital Diseases, Male / etiology
-
Humans
-
Lymphogranuloma Venereum / drug therapy
-
Lymphogranuloma Venereum / etiology
-
Macrolides / therapeutic use
-
Male
-
Mass Screening / methods
-
Pelvic Inflammatory Disease / diagnosis
-
Pelvic Inflammatory Disease / drug therapy
-
Pelvic Inflammatory Disease / etiology
-
Penicillins / therapeutic use
-
Quinolones / therapeutic use
-
Tetracyclines / therapeutic use
-
United Kingdom / epidemiology
Substances
-
Anti-Bacterial Agents
-
Anti-Infective Agents
-
Macrolides
-
Penicillins
-
Quinolones
-
Tetracyclines